CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19.

Gregersen I, Ueland T, Holter JC, Olsen MB, Michelsen AE, Murphy SL, Tveita AA, Henriksen KN, Hoel H, Nordberg LB, Holten AR, Edvardsen T, Yang K, Heggelund L, Trøseid M, Müller F, Kildal AB, Dyrhol-Riise AM, Barratt-Due A, Dahl TB, Aukrust P, Halvorsen B, NOR-SOLIDARITY consortium, The Norwegian SARS-CoV-2 Study Group investigators

Open source

DOI
10.1016/j.jinf.2022.09.029
Published
2022 Dec
Container
The Journal of infection
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jinf.2022.09.029,
  title = {CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19.},
  author = {Gregersen I and Ueland T and Holter JC and Olsen MB and Michelsen AE and Murphy SL and Tveita AA and Henriksen KN and Hoel H and Nordberg LB and Holten AR and Edvardsen T and Yang K and Heggelund L and Trøseid M and Müller F and Kildal AB and Dyrhol-Riise AM and Barratt-Due A and Dahl TB and Aukrust P and Halvorsen B and NOR-SOLIDARITY consortium, The Norwegian SARS-CoV-2 Study Group investigators},
  year = {2022},
  journal = {The Journal of infection},
  doi = {10.1016/j.jinf.2022.09.029},
  url = {https://doi.org/10.1016/j.jinf.2022.09.029}
}

RIS

TY  - JOUR
TI  - CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19.
AU  - Gregersen I
AU  - Ueland T
AU  - Holter JC
AU  - Olsen MB
AU  - Michelsen AE
AU  - Murphy SL
AU  - Tveita AA
AU  - Henriksen KN
AU  - Hoel H
AU  - Nordberg LB
AU  - Holten AR
AU  - Edvardsen T
AU  - Yang K
AU  - Heggelund L
AU  - Trøseid M
AU  - Müller F
AU  - Kildal AB
AU  - Dyrhol-Riise AM
AU  - Barratt-Due A
AU  - Dahl TB
AU  - Aukrust P
AU  - Halvorsen B
AU  - NOR-SOLIDARITY consortium, The Norwegian SARS-CoV-2 Study Group investigators
PY  - 2022
JO  - The Journal of infection
DO  - 10.1016/j.jinf.2022.09.029
UR  - https://doi.org/10.1016/j.jinf.2022.09.029
ER  - 

APA

I, G., T, U., JC, H., MB, O., AE, M., SL, M., AA, T., KN, H., H, H., LB, N., AR, H., T, E., K, Y., L, H., M, T., F, M., AB, K., AM, D., A, B., TB, D., P, A., B, H., & investigators, N. C. T. N. S. S. G. (2022). CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19.. The Journal of infection. https://doi.org/10.1016/j.jinf.2022.09.029

Source records